Research Library

What's behind the rise of U.S. manufacturers “nearshoring” to Mexico? In this report, fellow David A. Gantz explores the historical drivers fueling this trend and the reasons why Mexico may struggle to attract foreign investment in the near future.

The 2024 Mexico Country Outlook report analyzes key policy issues ahead of Mexico’s June 2024 elections, from foreign investment and regulatory challenges to migration and public security.

Fellow Gabriel Collins and Andrew S. Erickson explore the possibility of China taking control of Taiwan’s world-leading chip industry without ever invading — and lay out a strategy to prevent such a conquest by Beijing.

In this report, the authors outline the U.S. federal budget process for scientific R&D, discuss trends in federal R&D funding and provide an outlook for federal scientific R&D funding during the Biden administration.

In a comprehensive update to their 2014 study on the future of American innovation, the Baker Institute and the American Academy of Arts and Sciences conclude that significant policy and funding actions are required to ensure the U.S. does not lose its preeminent position in discovery and innovation.

The sharing economy — an industry that includes a number of mostly online enterprises such as Uber and Airbnb that match service providers with clients — poses sweeping legal, commercial and social challenges. Fellow Joyce Beebe analyzes key federal tax considerations for companies and workers in this growing sector.

The core strategies of the U.S. War on Drugs are eradication, interdiction and incarceration. After a 40-year and trillion-dollar effort, illicit drugs remain available to meet a remarkably stable demand. Drawing on decades of government-gathered and publicly available data, William Martin, director of the Drug Policy Program, and contributing expert Jerry Epstein contend that U.S. drug policy is premised on incorrect assumptions, aims at the wrong targets and can never succeed. But because these data run counter to a century of anti-drug propaganda, they play only a small role in public policy, mass-media presentation and popular perception. In this policy report, Martin and Epstein call for a reexamination of the data and sweeping revision of existing strategies. They urge formation of a politically independent national scientific commission, its members chosen by the National Academy of Sciences, in consultation with the NIH and the Department of Health and Human Services, to facilitate open examination and honest consideration of alternatives to current failed or flawed policies.

Paper part of Energy Forum study "The Energy Dimension in Russian Global Strategy"

Richard Stoll, Baker Institute Rice…